In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Evidence-Based Complementary and Alternative Medicine, 2022, S. 8038195-
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2022
- Event
-
Veröffentlichung
- (who)
-
Hindawi Limited
- (when)
-
2022
- Creator
- DOI
-
10.1155/2022/8038195
- URN
-
urn:nbn:de:bvb:384-opus4-1157336
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:47 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tran, Hoai Thi Thu
- Peterburs, Philipp
- Seibel, Jan
- Abramov-Sommariva, D.
- Lamy, Evelyn
- Universität Augsburg
- Hindawi Limited
Time of origin
- 2022
Other Objects (12)
In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2
SARS-CoV-2-Arbeitsschutzstandard
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 und Medikamenten
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
Biostoffverordnung : Basiskommentar zur BiostoffV mit SARS-CoV-2-Arbeitsschutzstandard und SARS-CoV-2-Arbeitsschutzregel
Aprotinin inhibits SARS-CoV-2 replication
Broschüre "Phantom-Virus 'SARS-CoV-2'"
SARS-CoV-2-Arbeitsschutzstandard und -Arbeitsschutzregel
In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2
SARS-CoV-2-Arbeitsschutzstandard
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 und Medikamenten
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
Biostoffverordnung : Basiskommentar zur BiostoffV mit SARS-CoV-2-Arbeitsschutzstandard und SARS-CoV-2-Arbeitsschutzregel
Aprotinin inhibits SARS-CoV-2 replication
Broschüre "Phantom-Virus 'SARS-CoV-2'"
SARS-CoV-2-Arbeitsschutzstandard und -Arbeitsschutzregel
In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2
SARS-CoV-2-Arbeitsschutzstandard
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 und Medikamenten
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
Biostoffverordnung : Basiskommentar zur BiostoffV mit SARS-CoV-2-Arbeitsschutzstandard und SARS-CoV-2-Arbeitsschutzregel
Aprotinin inhibits SARS-CoV-2 replication
Broschüre "Phantom-Virus 'SARS-CoV-2'"